Public Employees Retirement System of Ohio purchased a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 12,584 shares of the medical technology company's stock, valued at approximately $1,595,000.
Several other institutional investors have also recently made changes to their positions in TFX. Corient Private Wealth LP bought a new stake in Teleflex in the 2nd quarter valued at about $3,006,000. Bank of America Corp DE bought a new position in Teleflex in the second quarter worth approximately $61,156,000. Boone Capital Management LLC bought a new position in Teleflex in the second quarter worth approximately $49,105,000. Freestone Grove Partners LP acquired a new stake in Teleflex in the second quarter valued at approximately $9,070,000. Finally, Man Group plc acquired a new stake in Teleflex in the second quarter valued at approximately $1,686,000. Institutional investors and hedge funds own 95.62% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently commented on TFX. Mizuho boosted their price objective on Teleflex from $140.00 to $145.00 and gave the company a "neutral" rating in a report on Wednesday, July 15th. Truist Financial increased their target price on Teleflex from $143.00 to $150.00 and gave the stock a "hold" rating in a report on Monday, August 10th. Wall Street Zen raised shares of Teleflex from a "sell" rating to a "hold" rating in a research report on Sunday, August 9th. UBS Group upped their price objective on shares of Teleflex from $145.00 to $158.00 and gave the stock a "neutral" rating in a report on Tuesday, August 11th. Finally, BMO Capital Markets began coverage on Teleflex in a report on Wednesday, July 8th. They set an "outperform" rating and a $159.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Teleflex currently has a consensus rating of "Hold" and an average price target of $152.90.
Read Our Latest Stock Report on TFX
Teleflex Stock Performance
NYSE TFX opened at $138.21 on Tuesday. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $145.00. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The firm has a market cap of $5.86 billion, a price-to-earnings ratio of -5.93, a PEG ratio of 0.92 and a beta of 0.82. The company has a fifty day moving average price of $135.50 and a 200-day moving average price of $127.52.
Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same quarter in the prior year, the company posted $3.73 earnings per share. The firm's revenue for the quarter was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.
Teleflex Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex's dividend payout ratio (DPR) is currently -5.84%.
Teleflex Company Profile
(
Free Report)
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.